xista science ventures

Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. The company specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses responsible for colds and flu infections. Its primary product, a targeted therapy utilizing 2-deoxyglucose, disrupts the metabolic processes of host cells, thereby hindering viral replication both in vitro and in vivo, particularly against rhinovirus. By employing a novel host cell-based strategy, G.ST Antivirals aims to create broad-spectrum antiviral treatments that address unmet medical needs in the management of respiratory tract infections.

Hephaistos Pharma is a biotechnology company focused on advancing oncology treatments through innovative immunotherapy solutions. The firm develops a platform that utilizes active and non-specific immuno-stimulants to enhance the effectiveness of existing antibodies by transforming cold tumors into hot targets, which can significantly improve patient outcomes. This approach aims to address unmet medical needs in cancer treatment, enabling patients to tackle previously incurable cancers. Hephaistos Pharma is dedicated to elevating immunotherapy efficiency by stimulating immune responses, thereby offering new hope in the fight against cancer. Interested parties can access more information through an online inquiry form available on the company's website.

Rivus Batteries is a green technology company specializing in sustainable energy storage solutions through its innovative, metal-free flow battery technology. By utilizing water-based organic electrolytes made from abundantly available elements, Rivus aims to provide a cost-effective and environmentally friendly alternative for long-duration energy storage. The company's focus on developing novel organic electrolytes not only enhances the efficiency of energy storage systems but also minimizes the environmental impact associated with traditional battery technologies. With its commitment to pioneering eco-friendly solutions, Rivus is positioned to contribute significantly to the advancement of grid-scale energy storage.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

infrared.city is a platform for intelligent and resilient design powered by Artificial Intelligence. We make complex climate simulations accessible and understandable for all stakeholders of the built environment. Our state-of-the-art machine learning models provide real-time feedback on the performance of design proposals and can guide climate informed decisions at every step of the design process. For more information, please visit www.infrared.city

subdron focuses on data processing in underwater inspections and autonomous underwater navigation.

ReCatalyst specializes in the development and commercialization of advanced platinum-alloy catalysts for hydrogen fuel cells. The company focuses on creating next-generation nano-catalysts that enhance stability and reduce the amount of platinum needed in each fuel cell system. By optimizing the use of platinum group metals, ReCatalyst enables significant scalability of high-power proton exchange membrane fuel cells. This innovative approach aims to improve the efficiency and affordability of fuel cell technology, positioning the company as a key player in the clean energy sector.

Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.

Sarcura GmbH is an Austrian deep-tech startup founded in 2019, focused on developing a machine platform for the large-scale industrial manufacturing of personalized cell therapies aimed at treating cancer. The company leverages innovative semiconductor technology and microfluidic processing to achieve real-time control and manipulation at the cellular level. This approach facilitates a fully automated and modular manufacturing system, which enhances the efficiency and safety of producing advanced cell therapies tailored to individual patient needs. Sarcura's platform represents a significant shift in manufacturing paradigms, contributing to more accessible and cost-effective treatment options for patients. The company operates from Hinterstoder, Austria.

Brightmind.ai is focused on developing innovative neuromodulation technology aimed at improving brain health through personalized, at-home solutions. The company utilizes advanced artificial intelligence to deliver tailored brain stimulation that targets individual brain wave oscillations. This approach not only enhances the effectiveness of therapies but also allows users to monitor their progress through biofeedback. Brightmind.ai addresses significant challenges in brain health, including pain relief, cognitive decline, and depression, with its initial focus on migraine treatment. Current migraine therapies often leave many patients dissatisfied, but research indicates that Brightmind.ai's stimulation protocol can reduce migraine attacks by over 50% for a substantial portion of those affected. The company's vision is to make these personalized neurotechnology solutions accessible to individuals worldwide, ultimately improving outcomes for millions suffering from brain-related issues.

Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.

Brainhero is a life science company that specializes in home-based neurofeedback therapy aimed at addressing neurological impairments, particularly Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD). The company offers a playful approach to brain training, allowing children to learn how to control their brain activity through the measurement of brain waves using electroencephalogram (EEG) technology. This data is visualized in a user-friendly app, facilitating an engaging experience for young users. Brainhero's services extend beyond ASD and ADHD to include other neurological issues such as intellectual disabilities, epilepsy, and anxiety. Additionally, the company provides mobile neurofeedback training that helps improve concentration and relaxation, assisting medical practitioners in early detection of neurological problems and supporting appropriate medication management for patients.

CellEctric is a company focused on integrating electrodynamics with biology to enhance life science applications. Founded in early 2021, it is developing a platform that simplifies complex biological samples into single-population solutions. The initial application of this technology targets the isolation of viable bacteria from human samples, significantly speeding up sepsis diagnosis. CellEctric's platform offers a flexible approach to biological sample preparation, enabling laboratories to efficiently remove unwanted cells and improve the detection of pathogens. Future developments aim to include the isolation of leukocytes from whole blood and the creation of a customizable platform for separating similar mammalian cell populations with high throughput. Overall, CellEctric is committed to advancing healthcare through innovative technology that promotes faster and more precise diagnostics.

Ribbon Biolabs GmbH, founded in 2018 and based in Vienna, Austria, specializes in the synthesis of long deoxyribonucleic acid (DNA) molecules. The company employs innovative techniques to produce DNA of unprecedented lengths, setting new standards in molecular biology. Its services cater to the diverse needs of synthetic biology, supporting researchers and companies in various applications, including genome construction, high-throughput library creation, and the development of DNA-based products and nanotechnology devices. By enabling the synthesis of long DNA sequences without economic or time constraints, Ribbon Biolabs aims to advance the next wave of biotechnologies and facilitate cutting-edge research in genetic solutions.

Nista.io offers a cloud-based platform that converts energy data into actionable insights for industrial companies. Its software integrates information from manufacturing facilities to identify custom improvement measures, enabling businesses to optimize their energy consumption. By implementing these measures, Nista.io helps companies reduce annual energy costs by up to 20 percent and supports long-term reductions in CO₂ emissions. The platform empowers organizations to make informed operational decisions that significantly impact their energy efficiency.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced liquid-crystal display (LCD) backlighting solutions. The company utilizes glass-based waveguides and laser-powered photonic integrated circuits to create a groundbreaking quantum light chip that enhances display technology. This innovation replaces traditional backlight units with dedicated light sources for each sub-pixel, significantly improving energy efficiency, brightness, contrast ratio, and color rendering. VitreaLab's technology is designed to deliver high-quality illumination for 3D, virtual reality (VR), and augmented reality (AR) applications, offering unparalleled brightness and color quality while consuming less energy than competing solutions.

contextflow GmbH is a company based in Vienna, Austria, specializing in machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, it has developed a 3D image-based search engine that enables radiologists to quickly identify regions of interest in medical images, particularly in lung CT scans. This technology allows for the rapid retrieval of similar cases and relevant clinical information, enhancing decision-making processes in diagnostics. contextflow's software is designed to integrate seamlessly with existing radiology workflows, thereby improving efficiency and patient care. The company has established strategic partnerships with various organizations, including radiology centers and health associations, and is currently conducting trials of its software with multiple partners. Recognized for its innovation, contextflow has received several awards and was selected to participate in an accelerator program aimed at advancing health technology.

Rivus Batteries is a green technology company specializing in sustainable energy storage solutions through its innovative, metal-free flow battery technology. By utilizing water-based organic electrolytes made from abundantly available elements, Rivus aims to provide a cost-effective and environmentally friendly alternative for long-duration energy storage. The company's focus on developing novel organic electrolytes not only enhances the efficiency of energy storage systems but also minimizes the environmental impact associated with traditional battery technologies. With its commitment to pioneering eco-friendly solutions, Rivus is positioned to contribute significantly to the advancement of grid-scale energy storage.

Sarcura GmbH is an Austrian deep-tech startup founded in 2019, focused on developing a machine platform for the large-scale industrial manufacturing of personalized cell therapies aimed at treating cancer. The company leverages innovative semiconductor technology and microfluidic processing to achieve real-time control and manipulation at the cellular level. This approach facilitates a fully automated and modular manufacturing system, which enhances the efficiency and safety of producing advanced cell therapies tailored to individual patient needs. Sarcura's platform represents a significant shift in manufacturing paradigms, contributing to more accessible and cost-effective treatment options for patients. The company operates from Hinterstoder, Austria.

Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. The company specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses responsible for colds and flu infections. Its primary product, a targeted therapy utilizing 2-deoxyglucose, disrupts the metabolic processes of host cells, thereby hindering viral replication both in vitro and in vivo, particularly against rhinovirus. By employing a novel host cell-based strategy, G.ST Antivirals aims to create broad-spectrum antiviral treatments that address unmet medical needs in the management of respiratory tract infections.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced liquid-crystal display (LCD) backlighting solutions. The company utilizes glass-based waveguides and laser-powered photonic integrated circuits to create a groundbreaking quantum light chip that enhances display technology. This innovation replaces traditional backlight units with dedicated light sources for each sub-pixel, significantly improving energy efficiency, brightness, contrast ratio, and color rendering. VitreaLab's technology is designed to deliver high-quality illumination for 3D, virtual reality (VR), and augmented reality (AR) applications, offering unparalleled brightness and color quality while consuming less energy than competing solutions.

Ribbon Biolabs GmbH, founded in 2018 and based in Vienna, Austria, specializes in the synthesis of long deoxyribonucleic acid (DNA) molecules. The company employs innovative techniques to produce DNA of unprecedented lengths, setting new standards in molecular biology. Its services cater to the diverse needs of synthetic biology, supporting researchers and companies in various applications, including genome construction, high-throughput library creation, and the development of DNA-based products and nanotechnology devices. By enabling the synthesis of long DNA sequences without economic or time constraints, Ribbon Biolabs aims to advance the next wave of biotechnologies and facilitate cutting-edge research in genetic solutions.

Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.

contextflow GmbH is a company based in Vienna, Austria, specializing in machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, it has developed a 3D image-based search engine that enables radiologists to quickly identify regions of interest in medical images, particularly in lung CT scans. This technology allows for the rapid retrieval of similar cases and relevant clinical information, enhancing decision-making processes in diagnostics. contextflow's software is designed to integrate seamlessly with existing radiology workflows, thereby improving efficiency and patient care. The company has established strategic partnerships with various organizations, including radiology centers and health associations, and is currently conducting trials of its software with multiple partners. Recognized for its innovation, contextflow has received several awards and was selected to participate in an accelerator program aimed at advancing health technology.